Cross-linking for Corneal Ulcers Treatment Trial

Launched by UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · Oct 6, 2015

Keywords

ClinConnect Summary

The proposed study is a randomized controlled trial to determine whether collagen cross-linking improves outcomes in microbial keratitis. Patients presenting to the Aravind Eye Hospitals in Madurai, India for treatment of microbial keratitis will be recruited for the proposed study. Approximately 266 patients will be enrolled in the study. Subjects presenting with bacterial keratitis will be randomized to receive medical therapy plus corneal collagen cross-linking at presentation or to receive medical therapy alone. All subjects with bacterial ulcers will receive standard topical antibiotic...

Gender

ALL

Eligibility criteria

• Inclusion criteria:
• • Corneal ulcer that is smear positive for either bacteria or filamentous fungus
• • Pinhole visual acuity worse than 20/70 in the affected eye
• • Not treated already with antimicrobial medications at presentation
• • Age over 18 years
• • Basic understanding of the study as determined by the physician
• • Commitment to return for follow up visits
• Exclusion criteria:
• • Evidence of concomitant infection on exam or gram stain (i.e. herpes, both bacteria and acanthamoeba on gram stain)
• • Impending or frank perforation at recruitment
• • Involvement of sclera at presentation
• • Non-infectious or autoimmune keratitis
• • History of corneal transplantation or recent intraocular surgery
• • No light perception in the affected eye
• • Pinhole visual acuity worse than 20/200 in the unaffected eye
• • Participants who are decisionally and/or cognitively impaired